XPA A23G polymorphism and susceptibility to cancer: a meta-analysis.
about
Molecular epidemiology of DNA repair gene polymorphisms and head and neck cancer.Allele and genotype distributions of DNA repair gene polymorphisms in South Indian healthy population.Predictive effect of XPA and XPD polymorphisms on survival of advanced NSCLC patients treated with platinum-based chemotherapy: a three-dimensional (3-D), polyacrylamide gel-based DNA microarray method.XPA A23G polymorphism and risk of digestive system cancers: a meta-analysis.Association of the XPA A23G polymorphism with the risk of head and neck carcinomas: Evidence from 5,491 subjects.Potential risk of esophageal squamous cell carcinoma due to nucleotide excision repair XPA and XPC gene variants and their interaction among themselves and with environmental factors.A Functional Polymorphism (rs10817938) in the XPA Promoter Region Is Associated with Poor Prognosis of Oral Squamous Cell Carcinoma in a Chinese Han Population.Modulation of Colorectal Cancer Risk by Polymorphisms in 51Gln/His, 64Ile/Val, and 148Asp/Glu of APEX Gene; 23Gly/Ala of XPA Gene; and 689Ser/Arg of ERCC4 Gene.DNA repair gene variants in relation to overall cancer risk: a population-based studyFunctional analysis of Rad14p, a DNA damage recognition factor in nucleotide excision repair, in regulation of transcription in vivoSingle nucleotide polymorphisms in DNA repair genes and putative cancer risk.Structural dynamics and interactions of Xeroderma pigmentosum complementation group A (XPA98-210) with damaged DNA.Associations between expression levels of nucleotide excision repair proteins in lymphoblastoid cells and risk of squamous cell carcinoma of the head and neck.Association of XPA polymorphism with breast cancer risk: A meta-analysis.
P2860
Q28383483-274AF167-6D56-403D-86C6-EF13FB3ED1F0Q34657153-22CA4B12-836D-4CE7-BF5A-1149BC8B3D14Q34686858-CC56ACDD-19FF-4DBA-9949-9CCED7039CF3Q35094323-43ED59CF-F273-428F-AA5D-F8B2088CCA62Q35681493-1FC16321-15FC-4403-93C4-0289D98CD238Q35910570-D1B5A7DB-BCC9-4D61-9EC4-7DCBFC10AC5FQ36131135-16BB872A-55F2-49A6-8996-8251A3C172F0Q36339143-FEB085E5-4B4F-4441-A23D-495FAC9C5384Q36499747-02F2A78B-502F-4053-B116-42D5DE0269ABQ36526349-FE2E6ADB-3E3C-4282-BEA0-0BF0DF1A6E56Q38873757-5F735CEA-7C3A-42CD-A7E8-65BE1B94275FQ47704870-8C91AB35-222E-4F16-B089-6B031ABC0CB9Q52661245-01E9F999-560F-403E-BF5D-CE246A854B07Q55691604-CDB60973-36B0-46CB-909A-E2F330671025
P2860
XPA A23G polymorphism and susceptibility to cancer: a meta-analysis.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
XPA A23G polymorphism and susceptibility to cancer: a meta-analysis.
@ast
XPA A23G polymorphism and susceptibility to cancer: a meta-analysis.
@en
XPA A23G polymorphism and susceptibility to cancer: a meta-analysis.
@nl
type
label
XPA A23G polymorphism and susceptibility to cancer: a meta-analysis.
@ast
XPA A23G polymorphism and susceptibility to cancer: a meta-analysis.
@en
XPA A23G polymorphism and susceptibility to cancer: a meta-analysis.
@nl
prefLabel
XPA A23G polymorphism and susceptibility to cancer: a meta-analysis.
@ast
XPA A23G polymorphism and susceptibility to cancer: a meta-analysis.
@en
XPA A23G polymorphism and susceptibility to cancer: a meta-analysis.
@nl
P2093
P2860
P1476
XPA A23G polymorphism and susceptibility to cancer: a meta-analysis.
@en
P2093
Da-Peng Lei
Xiao-Lin Cao
Xin-Liang Pan
Zhen Zhang
Zhong-Qiu Wang
P2860
P2888
P304
P356
10.1007/S11033-012-1504-4
P577
2012-06-01T00:00:00Z
P6179
1044549625